XML 13 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Balance Sheets - USD ($)
Sep. 30, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 5,523,824 $ 3,293,983
Short-term investments available-for-sale, at fair value 11,097,140 28,201,507
Accounts receivable 591,861 716,246
Inventory, net of allowance of $667,553 at September 30, 2016 and $284,319 at December 31, 2015 1,867,685 2,201,301
Prepaid insurance 215,236 234,777
Prepaid expenses and other 226,070 210,440
Total current assets 19,521,816 34,858,254
Long-term investments available-for-sale, at fair value   2,603,901
Property and equipment, net 3,666,947 1,932,213
Total assets 23,188,763 39,394,368
Current liabilities:    
Accounts payable 1,117,830 724,805
Accrued liabilities 1,292,285 1,915,268
Deferred revenue 283,663 47,476
NuvoGen obligation 582,614 543,750
Term loan 6,254,688 3,059,068
Other current liabilities 270,041 29,243
Total current liabilities 9,801,121 6,319,610
Term loan payable - non-current, net of discount and debt issuance costs 6,902,379 7,737,586
NuvoGen obligation - non-current, net of discount 8,169,861 8,415,122
Other 530,159 28,652
Total liabilities 25,403,520 22,500,970
Commitments and Contingencies
Stockholders’ equity (deficit):    
Common stock, $0.001 par value; 200,000,000 shares authorized at September 30, 2016 and December 31, 2015, 7,060,269 and 7,058,873 shares issued and outstanding, respectively, at September 30, 2016, 6,845,638 and 6,844,242 shares issued and outstanding, respectively, at December 31, 2015 7,059 6,844
Additional paid-in-capital 107,786,467 106,569,405
Treasury stock – 1,396 shares, at cost (75,000) (75,000)
Accumulated other comprehensive loss (320) (41,357)
Accumulated deficit (109,932,963) (89,566,494)
Total stockholders’ equity (deficit) (2,214,757) 16,893,398
Total liabilities and stockholders' equity (deficit) $ 23,188,763 $ 39,394,368